Form 8-K - Current report:
SEC Accession No. 0000929638-24-000753
Filing Date
2024-02-23
Accepted
2024-02-23 16:30:46
Documents
16
Period of Report
2024-02-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 a8k.htm   iXBRL 8-K 24852
2 exhibit99-1.htm EX-99.1 6318
6 image00001.jpg GRAPHIC 2652
  Complete submission text file 0000929638-24-000753.txt   163034

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA adxs-20240220.xsd EX-101.SCH 3857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE adxs-20240220_lab.xml EX-101.LAB 20567
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adxs-20240220_pre.xml EX-101.PRE 14630
17 EXTRACTED XBRL INSTANCE DOCUMENT a8k_htm.xml XML 3774
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Ayala Pharmaceuticals, Inc. (Filer) CIK: 0001100397 (see all company filings)

EIN.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36138 | Film No.: 24671713
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)